These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 19116770)
1. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Vessal G; Mardani Z; Mollai M Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770 [TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran. Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159 [TBL] [Abstract][Full Text] [Related]
3. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Toklu HZ; Uysal MK Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373 [TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report). Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754 [TBL] [Abstract][Full Text] [Related]
5. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Su C; Ji H; Su Y Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911 [TBL] [Abstract][Full Text] [Related]
6. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518 [TBL] [Abstract][Full Text] [Related]
7. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344 [TBL] [Abstract][Full Text] [Related]
8. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists. Lemay J; Alsaleh FM; Al-Buresli L; Al-Mutairi M; Abahussain EA; Bayoud T Med Princ Pract; 2018; 27(1):30-38. PubMed ID: 29402876 [TBL] [Abstract][Full Text] [Related]
9. Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Hanafi S; Torkamandi H; Hayatshahi A; Gholami K; Javadi M Iran J Nurs Midwifery Res; 2012 Jan; 17(1):21-5. PubMed ID: 23492864 [TBL] [Abstract][Full Text] [Related]
10. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study. Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223 [TBL] [Abstract][Full Text] [Related]
11. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. Adisa R; Omitogun TI BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034 [TBL] [Abstract][Full Text] [Related]
12. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta. Curtolo E; Micallef B; Szijj JV; Serracino-Inglott A; Borg JJ Int J Risk Saf Med; 2024; 35(3):271-286. PubMed ID: 38820023 [TBL] [Abstract][Full Text] [Related]
13. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543 [TBL] [Abstract][Full Text] [Related]
14. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Li R; Curtain C; Bereznicki L; Zaidi STR Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819 [TBL] [Abstract][Full Text] [Related]
15. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583 [TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation. Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598 [TBL] [Abstract][Full Text] [Related]
17. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan. Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department. Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501 [TBL] [Abstract][Full Text] [Related]
19. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Stewart D; MacLure K; Paudyal V; Hughes C; Courtenay M; McLay J Int J Clin Pharm; 2013 Apr; 35(2):268-74. PubMed ID: 23277419 [TBL] [Abstract][Full Text] [Related]
20. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis. Terblanche A; Meyer JC; Godman B; Summers RS Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]